StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $55.24 | $59.61 | +7.91% | 0.7M |
| 05-12 | $59.16 | $69.54 | +17.55% | 0.7M |
| 05-13 | $68.30 | $72.01 | +5.43% | 0.5M |
| 05-14 | $72.01 | $78.49 | +9.00% | 0.4M |
| 05-15 | $78.67 | $81.73 | +3.89% | 0.4M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.42B | $5.93B | $4.36B | $2.93B |
Operating Income | $4.00M | $-463.24M | $-269.41M | $-138.14M |
Net Income | $48.92M | $-391.35M | $-202.47M | $-92.26M |
EPS (Diluted) | $2.94 | $-0.98 | $-0.52 | $-0.25 |
Total Assets | $1.50B | $1.27B | $1.60B | $1.71B |
Total Liabilities | $1.32B | $1.14B | $1.29B | $1.30B |
Cash & Equivalents | $139.99M | $173.71M | $171.68M | $171.42M |
Free Cash Flow OCF − CapEx | $20.63M | $-119.00M | $-95.50M | $-74.17M |
Shares Outstanding | 16.61M | 16.59M | 414.57M | 414.28M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.